Ajei Gopal - 10 Oct 2023 Form 4 Insider Report for ANSYS INC (ANSS)

Role
President and CEO, Director
Signature
Janet Lee, Attorney-in-Fact
Issuer symbol
ANSS
Transactions as of
10 Oct 2023
Transactions value $
-$6,460,812
Form type
4
Filing time
12 Oct 2023, 17:19:43 UTC
Previous filing
20 Jul 2023
Next filing
16 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANSS Common Stock Options Exercise $1,254,617 +13,194 +6.2% $95.09 227,171 10 Oct 2023 Direct
transaction ANSS Common Stock Sale -$3,876,315 -12,693 -5.6% $305.39 214,478 10 Oct 2023 Direct F1, F2
transaction ANSS Common Stock Sale -$153,376 -501 -0.23% $306.14 213,977 10 Oct 2023 Direct F1, F3
transaction ANSS Common Stock Options Exercise $1,166,754 +12,270 +5.7% $95.09 226,247 11 Oct 2023 Direct
transaction ANSS Common Stock Sale -$3,745,172 -12,270 -5.4% $305.23 213,977 11 Oct 2023 Direct F1
transaction ANSS Common Stock Options Exercise $500,553 +5,264 +2.5% $95.09 219,241 12 Oct 2023 Direct
transaction ANSS Common Stock Sale -$1,360,811 -4,457 -2% $305.32 214,784 12 Oct 2023 Direct F1, F4
transaction ANSS Common Stock Sale -$247,063 -807 -0.38% $306.15 213,977 12 Oct 2023 Direct F1, F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANSS Option to Purchase Options Exercise $0 -13,194 -10% $0 119,118 10 Oct 2023 Common Stock 13,194 $95.09 Direct F7
transaction ANSS Option to Purchase Options Exercise $0 -12,270 -10% $0 106,848 11 Oct 2023 Common Stock 12,270 $95.09 Direct F7
transaction ANSS Option to Purchase Options Exercise $0 -5,264 -4.9% $0 101,584 12 Oct 2023 Common Stock 5,264 $95.09 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Pursuant to an effective Rule 10b5-1 plan.
F2 The trade was executed in a series of transactions with a price range of $305.00 to $305.96, inclusive. The reporting person undertakes to provide to ANSYS, Inc., any security holder of ANSYS, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The trade was executed in a series of transactions with a price range of $306.04 to $306.20, inclusive. The reporting person undertakes to provide to ANSYS, Inc., any security holder of ANSYS, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F4 The trade was executed in a series of transactions with a price range of $305.00 to $305.97, inclusive. The reporting person undertakes to provide to ANSYS, Inc., any security holder of ANSYS, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F5 The trade was executed in a series of transactions with a price range of $306.03 to $306.31, inclusive. The reporting person undertakes to provide to ANSYS, Inc., any security holder of ANSYS, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F6 Includes 27,284 Deferred Stock Units and 71,129 Restricted Stock Units.
F7 The option grant of 208,882 shares granted on 08/31/2016 vested 25% annually in equal installments beginning on the first anniversary of the grant.